Search Clinical Trials
589,279 trials
ID
Status
Phase
Title
Sponsor
NCT07647315
Wireless Implantable Mandarin Chinese Speech Neuroprosthesis EvaluationShanghai StairMed Technology Co., Ltd.Not Yet RecruitingNot Applicable
NCT07647315Not Yet Recruiting
Not Applicable
Wireless Implantable Mandarin Chinese Speech Neuroprosthesis EvaluationShanghai StairMed Technol...
NCT07648550
Effect of Blood Flow Restriction Training on Quadriceps Muscle Architecture and Functional Abilities in Children With HemiplegiaCairo UniversityCompletedNot Applicable
NCT07648550Completed
Not Applicable
Effect of Blood Flow Restriction Training on Quadriceps Muscle Architecture and...Cairo University
NCT07648030
A Study of Rusfertide in Japanese Adults With Polycythemia VeraTakedaNot Yet RecruitingPhase 2
NCT07648030Not Yet Recruiting
Phase 2
A Study of Rusfertide in Japanese Adults With Polycythemia VeraTakeda
NCT07647120
Comparison of Freeze-Dried Amniotic and Collagen Membranes for Soft Tissue Healing After Grafted Implant SurgeryRAJAS DENTAL COLLEGE AND HOSPITALCompletedNot Applicable
NCT07647120Completed
Not Applicable
Comparison of Freeze-Dried Amniotic and Collagen Membranes for Soft Tissue Heali...RAJAS DENTAL COLLEGE AND...
NCT07648290
Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsThe Cleveland ClinicNot Yet RecruitingEarly Phase 1
NCT07648290Not Yet Recruiting
Early Phase 1
Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsThe Cleveland Clinic
NCT07648940
Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®) in Advanced Cancer PatientsZodiac Produtos Farmaceuticos S.A.CompletedPhase 1
NCT07648940Completed
Phase 1
Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®)...Zodiac Produtos Farmaceut...
NCT07647861
Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine HypersensitivityOndokuz Mayıs UniversityCompletedNot Applicable
NCT07647861Completed
Not Applicable
Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine HypersensitivityOndokuz Mayıs University
NCT07647289
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBCJiangsu Provincial People's HospitalRecruitingPhase 2
NCT07647289Recruiting
Phase 2
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBCJiangsu Provincial People...
NCT07647471
Evaluation of an Exercise Intervention During Intensive Medical Treatment in Pediatric Oncology.AOK Rheinland/HamburgNot Yet RecruitingNot Applicable
NCT07647471Not Yet Recruiting
Not Applicable
Evaluation of an Exercise Intervention During Intensive Medical Treatment in Ped...AOK Rheinland/Hamburg
NCT07648875
Water Vapor Thermal Therapy Versus Ejaculation-Preserving HoLEP for Benign Prostatic HyperplasiaBeni-Suef UniversityRecruitingNot Applicable
NCT07648875Recruiting
Not Applicable
Water Vapor Thermal Therapy Versus Ejaculation-Preserving HoLEP for Benign Prost...Beni-Suef University
NCT07648238
Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder MistreatmentNational Institute on Aging (NIA)Not Yet RecruitingNot Applicable
NCT07648238Not Yet Recruiting
Not Applicable
Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder MistreatmentNational Institute on Agi...
NCT07647900
Photography-Based Intervention for Children With Attention Deficit Hyperactivity DisorderThe Hong Kong Polytechnic UniversityActive Not RecruitingNot Applicable
NCT07647900Active Not Recruiting
Not Applicable
Photography-Based Intervention for Children With Attention Deficit Hyperactivity...The Hong Kong Polytechnic...
NCT07648251
Furosemide vs Placebo in Severe Preeclampsia PostpartumUniversidad Nacional Autonoma de HondurasNot Yet RecruitingPhase 2
NCT07648251Not Yet Recruiting
Phase 2
Furosemide vs Placebo in Severe Preeclampsia PostpartumUniversidad Nacional Auto...
NCT07648745
Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian CancerAstraZenecaCompletedPhase 2
NCT07648745Completed
Phase 2
Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian CancerAstraZeneca
NCT07647458
Quantifying Adhesive Residue on Skin Following Removal of Maxillofacial Prosthetic Adhesives: An In Vivo StudyAmrita Vishwa VidyapeethamCompletedNot Applicable
NCT07647458Completed
Not Applicable
Quantifying Adhesive Residue on Skin Following Removal of Maxillofacial Prosthet...Amrita Vishwa Vidyapeetha...
NCT07648693
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET TrialResonova (Shanghai) Medtech LimitedRecruitingNot Applicable
NCT07648693Recruiting
Not Applicable
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System...Resonova (Shanghai) Medte...
NCT07648849
Arthroscopic Versus Open Management of Lateral Epicondylitis Elbow (Randomized Control Trial)Assiut UniversityNot Yet RecruitingNot Applicable
NCT07648849Not Yet Recruiting
Not Applicable
Arthroscopic Versus Open Management of Lateral Epicondylitis Elbow (Randomized C...Assiut University
NCT07648368
Meditation as a Stress Management Strategy in Cardiac Rehabilitation for Coronary Artery Disease Patients: A Pilot Randomized Controlled TrialUniversidad Rey Juan CarlosCompletedNot Applicable
NCT07648368Completed
Not Applicable
Meditation as a Stress Management Strategy in Cardiac Rehabilitation for Coronar...Universidad Rey Juan Carl...
NCT07647367
Ultrasound Guided Subtransverse Interligamentary Block Versus Paravertebral Block for Quality of Recovery After Modified Radical MastectomyTanta UniversityNot Yet RecruitingNot Applicable
NCT07647367Not Yet Recruiting
Not Applicable
Ultrasound Guided Subtransverse Interligamentary Block Versus Paravertebral Bloc...Tanta University
NCT07647536
LLMs Improve Patient Understanding of Ultrasound ReportsLu WangActive Not RecruitingNot Applicable
NCT07647536Active Not Recruiting
Not Applicable
LLMs Improve Patient Understanding of Ultrasound ReportsLu Wang
Result Breakdown
Not yet recruiting8 (40%)
Completed7 (35%)
Recruiting3 (15%)
Active, not recruiting2 (10%)
not_applicable14 (70%)
Phase 24 (20%)
Early Phase 11 (5%)
Phase 11 (5%)